Rhodioloside attenuated atherosclerosis progression by inhibiting VCAM-1 gene transcription mediated by p65 activation and CSN5 deubiquitination in endothelial cells

Author:

Ji Jing1,Tang Wenlian1,Liu Xingquan2,Luo Lin3,Xin Xin3,Ju Nana3,Xiong Huarong3,Wu Ping3,Zhang Xian3,Zhang Daiwei3,Yu Lan3,Li Gen3,Zhao Feipeng3,Wang Jianing4,Liu Chao2,Zhang Xu3

Affiliation:

1. Jiangsu Ocean University

2. Nanjing Medical University

3. Affiliated Hospital of Integrated Traditional Chinese and Western Medicine of Chengdu Medical College

4. The Affiliated Jiangning Hospital with Nanjing Medical University

Abstract

Abstract

Monocyte-endothelial cell adhesion played a pivotal role in the initial stages of Atherosclerosis (AS) progression, exacerbating lipid disturbance and worsening the condition. Rhodioloside (Rho), a renowned compound in traditional Chinese medicine, possesses diverse pharmacological attributes, including anti-inflammatory, antioxidant, anticancer, anti-metabolic dysregulation, and neuroprotective properties. However, the exact mechanism by which Rho exerts its anti-AS effect is still not fully understood. This study aimed to investigate the potential therapeutic benefits of Rho in combating AS. ApoE−/− mice were fed with a High Fat Diet (HFD) and administered Rho treatment. The investigation evaluated the expression levels of GATA2, CSN5, and VCAM-1 proteins in the endothelium of the aorta. The findings revealed that Rho treatment led to a reduction in the protein expression of GATA2, CSN5, and VCAM-1 in the aortic endothelium, accompanied by decreased phosphorylation of p65. Furthermore, Rho inhibited the ubiquitination of GATA2 and weakened the interaction between PP2Ac and I2PP2A. Additionally, Rho directly suppressed the transcriptional activity of the NF-κB subunit p65 by targeting the I2PP2A-PP2Ac axis.

Publisher

Springer Science and Business Media LLC

Reference39 articles.

1. Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt,M. S., … American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. (2022). Heart disease and stroke statistics—2022 update: a report from the American Heart Association. Circulation, 145(8), e153-e639.

2. Hu, S. S., Gao, R. L., Liu, L. S., Zhu, M. L., Wang, W., Wang, Y. J., … Chen, W. (2019).Summary of China cardiovascular disease report 2018. Chinese Circulation Journal, 34(03), 209–220

3. Endothelial glycocalyx, apoptosis and inflammation in an atherosclerotic mouse model;Cancel LM;Atherosclerosis,2016

4. Anti-inflammatory therapeutics for the treatment of atherosclerosis;Charo IF;Nat Rev Drug Discovery,2011

5. Effects of Huoxuoxu Traditional Chinese medicine on blood lipid and atherosclerotic plaque inflammation in ApoE gene-deficient mice;Wen Chuan X;Chin J Integr Traditional Western Med,2005

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3